Business Description
ISIN : US33817P4054
Total Employee Number:
81Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.46 | |||||
Debt-to-Equity | 0.81 | |||||
Debt-to-EBITDA | 3.24 | |||||
Interest Coverage | 4.29 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.7 | |||||
Beneish M-Score | -1.56 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 41.3 | |||||
3-Year EBITDA Growth Rate | 21.2 | |||||
3-Year EPS without NRI Growth Rate | 19.4 | |||||
3-Year FCF Growth Rate | 21.3 | |||||
3-Year Book Growth Rate | 25.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 38.1 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 14.07 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 48.76 | |||||
9-Day RSI | 48.12 | |||||
14-Day RSI | 47.69 | |||||
3-1 Month Momentum % | -1.93 | |||||
6-1 Month Momentum % | -36.09 | |||||
12-1 Month Momentum % | -48.39 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.46 | |||||
Quick Ratio | 0.45 | |||||
Cash Ratio | 0.05 | |||||
Days Inventory | 111.17 | |||||
Days Sales Outstanding | 25.7 | |||||
Days Payable | 38.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.4 | |||||
Shareholder Yield % | -31.98 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 36.54 | |||||
Operating Margin % | 11.9 | |||||
Net Margin % | 6.15 | |||||
EBITDA Margin % | 11.71 | |||||
FCF Margin % | 9.9 | |||||
OCF Margin % | 9.91 | |||||
ROE % | 14.21 | |||||
ROA % | 6.41 | |||||
ROIC % | 11.21 | |||||
3-Year ROIIC % | 5.86 | |||||
ROC (Joel Greenblatt) % | 70 | |||||
ROCE % | 14.56 | |||||
Years of Profitability over Past 10-Year | 9 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 16.29 | |||||
Forward PE Ratio | 11.68 | |||||
PE Ratio without NRI | 14.39 | |||||
Shiller PE Ratio | 28.06 | |||||
Price-to-Owner-Earnings | 11.72 | |||||
PEG Ratio | 0.73 | |||||
PS Ratio | 1.01 | |||||
PB Ratio | 2 | |||||
Price-to-Free-Cash-Flow | 10.04 | |||||
Price-to-Operating-Cash-Flow | 10.04 | |||||
EV-to-EBIT | 12.05 | |||||
EV-to-EBITDA | 11.15 | |||||
EV-to-Forward-EBITDA | 8.63 | |||||
EV-to-Revenue | 1.31 | |||||
EV-to-Forward-Revenue | 1.24 | |||||
EV-to-FCF | 13.19 | |||||
Price-to-GF-Value | 0.42 | |||||
Price-to-Projected-FCF | 0.73 | |||||
Price-to-Median-PS-Value | 0.65 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.82 | |||||
Earnings Yield (Greenblatt) % | 8.3 | |||||
FCF Yield % | 10.57 | |||||
Forward Rate of Return (Yacktman) % | 24.29 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:FTLF
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
FitLife Brands Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 101.269 | ||
| EPS (TTM) ($) | 0.62 | ||
| Beta | -0.4883 | ||
| 3-Year Sharpe Ratio | 0.16 | ||
| 3-Year Sortino Ratio | 0.26 | ||
| Volatility % | 67.49 | ||
| 14-Day RSI | 47.69 | ||
| 14-Day ATR ($) | 0.512186 | ||
| 20-Day SMA ($) | 10.12575 | ||
| 12-1 Month Momentum % | -48.39 | ||
| 52-Week Range ($) | 8.67 - 20.98 | ||
| Shares Outstanding (Mil) | 9.39 |
Piotroski F-Score Details
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
FitLife Brands Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
FitLife Brands Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-13 16:30 | In 78 days | ||
| Third quarter earnings results for 2026 | 2026-11-13 | In 77 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-13 16:30 | 10.26 (+4.59%) | ||
| Second quarter earnings results for 2026 | 2026-08-13 | 10.26 (+4.59%) | ||
| General meeting for 2026 | 2026-08-11 09:00 | 9.96 (-0.40%) | ||
| First quarter earnings conference call for 2026 | 2026-05-14 17:00 | 9.53 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-14 | 9.53 (+0.00%) | ||
| Annual report for 2025 | 2026-03-31 | 14.28 (+3.01%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-31 | 14.28 (+3.01%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-31 | 14.28 (+3.01%) |
FitLife Brands Inc Frequently Asked Questions
Guru Commentaries on NAS:FTLF
FitLife Brands reported disappointing figures, indicating challenges with legacy brands online sales had continued from the third quarter into the fourth. Changes to the Amazon product search algorithm directed fewer potential buyers to FitLife’s legacy products, and sales and margins for the company’s MusclePharm products were negatively affected by high whey protein prices. The company is working diligently to address the problem, but has not yet succeeded in reversing the decline. Despite these challenges, the acquisition of Irwin Naturals is performing well, generating cash well in excess of acquisition-related debt service costs.
FitLife Brands had a busy August, announcing and closing a deal to acquire Irwin Naturals, a major vitamins and supplements producer. The acquisition was funded with balance sheet cash and bank debt, and at $18, FitLife shares are trading at around 11x my estimate of 2026 free cash flow. Despite my reservations about the vitamins and supplements industry, my view of FitLife's leadership is glowing. CEO Dayton Judd has a talent for identifying valuable brands in distress and integrating them into FitLife's distribution. The market has responded positively to the Irwin Naturals acquisition, and I am confident that FitLife is just getting started.
FitLife Brands had a busy August, announcing and closing a deal to acquire Irwin Naturals, a major vitamins and supplements producer. The acquisition was funded with balance sheet cash and bank debt, and at $18, FitLife shares are trading at around 11x my estimate of 2026 free cash flow. Despite my reservations about the vitamins and supplements industry, my view of FitLife's leadership is glowing. CEO Dayton Judd has a talent for identifying valuable brands in distress and integrating them into FitLife's distribution. The market has responded positively to the Irwin Naturals acquisition, and I am confident that FitLife is just getting started.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||

